Summary
This study sheds new light on the role of acidic residues present in the active site cavity of human aromatase. Eight acidic residues (E129, D222, E245, E302, D309, E379, D380 and D476) lining the cavity are identified and studied using comparative modeling, docking, molecular dynamics as well as statistical techniques. The structural environment of these acidic residues is studied to assess the stability of the corresponding carboxylate anions. Results indicate that the environment of the residues E245, E302 and D222 is most suitable for carboxylate ion formation in the uncomplexed form. However, the stability of D309, D222 and D476 anions is seen to increase on complexation to steroidal substrates. In particular, the interaction between D309 and T310, which assists proton transfer, is found to be formed following androgen/nor-androgen complexation. The residue D309 is found to be clamped in the presence of substrate which is not observed in the case of the other residues although they exhibit changes in properties following substrate binding. Information entropic analysis indicates that the residues D309, D222 and D476 have more conformational flexibility compared to E302 and E245 prior to substrate binding. Interaction similar to that between D476 and D309, which is expected to assist androgen aromatization, is proposed between E302 and E245. The inhibition of aromatase activity by 4-hydroxy androstenedione (formestane) is attributed to a critical hydrogen bond formation between the hydroxy moiety and T310/D309 as well as the large distance from D476. The results corroborate well with earlier site directed mutagenesis studies.
Similar content being viewed by others
References
Thijssen H.H., (2004) Maturitas 49:25
Yue W., Santen R.J., Wang J.P., Li Y., Verderame M.F., Bocchinfuso W.P., Korach K.S., Devanesan P., Todorovic R., Rogan E.G., Cavalieri E.L., (2003) J. Steroid Biochem. Mol. Biol. 86:477
Meunier B., de Visser S.P., Shaik S., (2004) Chem. Rev. 104:3947
Akthar M., Robichund P.L., Akthar M.E., Wright J.N., (1997) J. Steroid Biochem. Mol. Biol. 61:127
Murthy J.N., Rao A.R.R., Sastry G.N., (2004) Curr. Med. Chem-Anti-Cancer Agent 4:523
Amarneh B., Corbin C.J., Peterson J.A., Simpson E.R., Grahm-Lorence S., (1993) Mol. Endocrinol., 7:1617
Chen S., Zhou D., Swiderek K.M., Kodohama N., Osawa Y., Hall P.F., (1993) J. Steroid. Biochem. Mol. Biol. 44:347
Kao Y.C., Cam L.L., Laughton C.A., Zhou D., Chen S., (1996) Cancer Res. 56:3451
Kodohama N., Yorborough C., Zhou D., Chen S., Osawa Y., Hall P.F., (1992) J. Steroid. Biochem. Mol. Biol. 43:693
Auvray P., Nativelle C., Bureau R., Dallemagne P., Seralini G.E., Sourdaine P., (2002) Eur. J. Biochem. 269:1393
Laughton C.A., Zvelebil M.J., Needle S., (1993) J. Steroid Biochem. Mol. Biol. 44:399
Blobaum A.L., Harris D.L., Hollenberg P.F., (2005) Biochemistry 44:3831
Chen S., Zhou D., (1992) J. Biol. Chem. 267:22587
Grahm-Lorence S., Amarneh B., White R.E., Peterson J.A., Simpson E.R., (1995) Protein Sci. 4:1065
Cavalli A., Greco G., Noellino E., Recanatini M., (2000) Bioorg. Med. Chem. 8:2771
de Graaf C., Vermeulen N.P.E., Feenstra K.N., (2005) J. Med. Chem. 48:2725
Williams P.A., Cosme J., Sridhar V., Johnson E.F., McRee D.E., (2000) J. Inorg. Biochem. 81:183
Wester M.R., Johnson E.F., Marques-Soares C., Dijols S., Dansette P.M., Mansuy D., Stout C.D., (2003) Biochemistry 42:9335
Matthew J.B., Gurd F.R.N., Garcia-Moreno E.B., Flanagan M.A., March K.L., Shire S.J., (1985) CRC Crit. Rev. Biochem. 18:91
Schutz C.N., Warshel A., (2001) Proteins 44:400
Warshel A., Russel S., (1984) Q Rev. Biophys. 17:283
Martin A.C., MacArthur M.W., Thortan J.M., (1997) Proteins (Suppl) 14
Sali A., Blundell T.L., (1993) J. Mol. Biol., 234:779
Luthy R., Bowie J.U., Eisenberg D., (1992) Nature 356:83
Kelley L.A., Mac Callum R.M., Sternberg M.J.E., (2000) J. Mol. Biol. 299:501
Shi, S., Yan, L., Yang, Y. and Fisher, J., ESFF Force Field Project Report II, Accelrys, San Diego
Jones D.T., (1999) J. Mol. Biol. 292:195
Exner T., Keil M., Moeckel G., Brickmann J., (1998) J. Mol. Model. 4:340
MDS 1.0: Molecular Design Suite, Vlife Sciences Technologies Pvt. Ltd., Pune, India, 2003
Sharp K.A., Nicholls A., Friedman R., Honig B., (1991) Biochemistry 30:9686
Schmidt A.B., Fine R.M., (1994) Mol. Simulat. 13:347
Bindu P.H., Sastry G.M., Murty U.S.N., Sastry G.N., (2004) Biochem. Biophys. Res. Commun. 319:312
Luthy B.A., Wasserman Z.R., Stouten P.F.W., Hodge C.N., Zacharias M., McCammon J.A., (1995) J. Comp. Chem. 16:454
Berendsen H.J.C., Postma J.P.M., van Gunsteren W., DiNola A., Haak J.R., (1984) J. Chem. Phys. 81:3684
Pearlman D.A., Case D.A., Cadwell J.W., Ross W.S., Cheatham T.E.I., DeBolt S., Ferguson D., (1995) Comput. Phys. Commun. 2:287
Shannon C.E., (1948) Bell Syst. Tech. J. 27:379
Gadre S.R., (1984) Phys. Rev A. 30:620
Auvray P., Moslemi S., Sourdaine P., Seralini G.E., Enguehard C., Dallemagne P., Sonnet P., Bureu P., Rault S., (1998) Eur. J. Med. Chem. 33:451
Thompson J.D., Higgins D.G., Gibson T.J., (1994) Nucleic Acids Res. 22:4673
Forsyth W.R., Antosiewicz J.M., Robertson A.D., (2002) Proteins 48:388
Wei J.Y., Pochapsky T.C., Pochapsky S.S., (2005) J. Am. Chem. Soc. 127:6974
Zhou D., Korzekwa K.R., Poulos T., Chen S., (1992) J. Biol. Chem. 267:762
Kao Y.C., Korzekwa K.R., Loughton C.A., Chen S., (2001) Eur. J. Biochem. 268:243
Acknowledgements
JNM. and NM. acknowledge financial assistance from UGC and CSIR respectively. GMS thanks DST for financial support.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Murthy, J., Nagaraju, M., Sastry, G. et al. Active site acidic residues and structural analysis of modelled human aromatase: A potential drug target for breast cancer. J Comput Aided Mol Des 19, 857–870 (2005). https://doi.org/10.1007/s10822-005-9024-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10822-005-9024-0